Perceptive Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.1M | Buy |
|
|||||
|
2025
Q1 | $11.1M | Hold |
|
|||||
|
2024
Q4 | $13.7M | Sell |
|
|||||
|
2024
Q3 | $24.5M | Sell |
|
|||||
|
2024
Q2 | $89.5M | Sell |
|
|||||
|
2024
Q1 | $111M | Buy |
|
|||||
|
2023
Q4 | $35.7M | Buy |
|
|||||
|
2023
Q3 | $17.9M | Buy |
|
|||||
|
2023
Q2 | $9.43M | Hold |
|
|||||
|
2023
Q1 | $10.1M | Hold |
|
|||||
|
2022
Q4 | $11.9M | Hold |
|
|||||
|
2022
Q3 | $10.6M | Sell |
|
|||||
|
2022
Q2 | $38.8M | Buy |
|
|||||
|
2022
Q1 | $37.1M | Sell |
|
|||||
|
2021
Q4 | $41.1M | Hold |
|
|||||
|
2021
Q3 | $46.3M | Sell |
|
|||||
|
2021
Q2 | $79M | Sell |
|
|||||
|
2021
Q1 | $91.6M | Sell |
|
|||||
|
2020
Q4 | $182M | Buy |
|
|||||
|
2020
Q3 | $149M | Sell |
|
|||||
|
2020
Q2 | $261M | Sell |
|
|||||
|
2020
Q1 | $265M | Sell |
|
|||||
|
2019
Q4 | $388M | Sell |
|
|||||
|
2019
Q3 | $366M | Buy |
|
|||||
|
2019
Q2 | $340M | Buy |
|
|||||
|
2019
Q1 | $331M | Sell |
|
|||||
|
2018
Q4 | $315M | Sell |
|
|||||
|
2018
Q3 | $587M | Buy |
|
|||||
|
2018
Q2 | $463M | Sell |
|
|||||
|
2018
Q1 | $395M | Sell |
|
|||||
|
2017
Q4 | $400M | Buy |
|
|||||
|
2017
Q3 | $294M | Buy |
|
|||||
|
2017
Q2 | $165M | Buy |
|
|||||
|
2017
Q1 | $146M | Buy |
|
|||||
|
2016
Q4 | $128M | Buy |
|
|||||
|
2016
Q3 | $125M | Sell |
|
|||||
|
2016
Q2 | $127M | Buy |
|
|||||
|
2016
Q1 | $108M | Buy |
|
|||||
|
2015
Q4 | $141M | Sell |
|
|||||
|
2015
Q3 | $117M | Sell |
|
|||||
|
2015
Q2 | $157M | Sell |
|
|||||
|
2015
Q1 | $149M | Buy |
|
|||||
|
2014
Q4 | $79.6M | Sell |
|
|||||
|
2014
Q3 | $71.5M | Sell |
|
|||||
|
2014
Q2 | $68.3M | Sell |
|
|||||
|
2014
Q1 | $74.4M | Buy |
|
|||||
|
2013
Q4 | $39.1M | Sell |
|
|||||
|
2013
Q3 | $48.3M | Sell |
|
|||||
|
2013
Q2 | $68M | Buy |
|